FDA issued a Warning Letter to Aztex Enterprises Ltd. on 10/20/2017 as a result of this inspection.
483 Aztex Enterprises Jun 2017
483 Aztex Enterprises Jun 2017John Mistler FDA$119.00 - Available Now
FDA investigators audited the Aztex Enterprises - Burlington, Canada facility and issued inspectional observations (via FDA 483) on 13 Jun 2017.
Add To Cart
- Category: Human Drugs
- Inspection end: 13 Jun 2017
- Location: Burlington, Canada
- FEI: 3003516782